Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

UK biotech Synairgen to begin COVID-19 trial of lead candidate

Company enters the race to find a therapeutic as virus cases rise

- PMLiVE

FDA knocks back DBV’s peanut allergy therapy once again

Drug loses further ground to Aimmune's Palforzia

AstraZeneca AZ

AZ’s Imfinzi plus tremelimumab combo misses again

Drug missed endpoint in small cell lung cancer trial

How can your exhibition stand maximise customer engagement?

Here’s the perennial question: whether you exhibit regularly or just in one or two major brand-specific shows, how do you turn your stand from a branded space with product and...

Apex Events and Exhibitions

- PMLiVE

Novartis launches $20m COVID-19 response fund

Financial grants will be issued to most impacted communities

- PMLiVE

NICE looks internally for new chief executive

Deputy chief exec Gillian Leng is set to take the helm

In Memory

Changing healthcare, one film at a time

Successfully marrying educational content with an entertaining format can help to truly maximise audience engagement

Bedrock Healthcare Communications

- PMLiVE

20 for 2020 – Five pharma leaders to watch in 2020

Five individuals we think will have a key role to play in the sector in 2020 and beyond

Courageous Conversations ep.5: Virtual Meetings During the COVID-19 Pandemic

Impetus Digital

Impetus Digital official statement on COVID-19

At Impetus Digital, the health and wellbeing of our staff, clients, advisors, and their families is always our top priority. Recently, we have seen high numbers of advisors cancel their...

Impetus Digital

“New models” for agency pitching. My “Top takeaways” from the PM Society event

Paul Morrissey, Global Business Director, OPEN Health

OPEN Health

- PMLiVE

Mapping the clinical and emotional journey to better understand lived experience

Written by OPEN Health's Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew

OPEN Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links